Risultati della ricerca - Nayak, Satyaprakash

Population Pharmacokinetic Analysis of Rivipansel in Healthy Subjects and Subjects with Sickle Cell Disease di Nayak, Satyaprakash, Tammara, Brinda, Harnisch, Lutz O.

Testo Testo Testo

Computational Modeling and Analysis of Insulin Induced Eukaryotic Translation Initiation di Lequieu, Joshua, Chakrabarti, Anirikh, Nayak, Satyaprakash, Varner, Jeffrey D.

Testo Testo Testo

Arsenic Trioxide (ATO) cooperates with All Trans Retinoic Acid (ATRA) to enhance MAPK activation and differentiation in Human Myeloblastic Leukemia (HL-60) cells di Nayak, Satyaprakash, Shen, Miaoqing, Varner, Jeffrey D., Yen, Andrew

Testo Testo Testo

Evaluating the Role of Janus Kinase Pathways in Platelet Homeostasis Using a Systems Modeling Approach di Koride, Sarita, Nayak, Satyaprakash, Banfield, Christopher, Peterson, Mark C.

Testo Testo Testo

Know Your Variability: Challenges in Mechanistic Modeling of Inflammatory Response in Inflammatory Bowel Disease (IBD) di Rogers, Katharine V., Bhattacharya, Indranil, Martin, Steven W., Nayak, Satyaprakash

Testo Testo Testo

A Test of Highly Optimized Tolerance Reveals Fragile Cell-Cycle Mechanisms Are Molecular Targets in Clinical Cancer Trials di Nayak, Satyaprakash, Salim, Saniya, Luan, Deyan, Zai, Michael, Varner, Jeffrey D.

Testo Testo Testo

Modeling and analysis of retinoic acid induced differentiation of uncommitted precursor cells() di Tasseff, Ryan, Nayak, Satyaprakash, Song, Sang Ok, Yen, Andrew, Varner, Jeffrey D.

Testo Testo Testo

Analysis of the Molecular Networks in Androgen Dependent and Independent Prostate Cancer Revealed Fragile and Robust Subsystems di Tasseff, Ryan, Nayak, Satyaprakash, Salim, Saniya, Kaushik, Poorvi, Rizvi, Noreen, Varner, Jeffrey D.

Testo Testo Testo

A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 1 – Model Framework di Rogers, Katharine V., Martin, Steven W., Bhattacharya, Indranil, Singh, Ravi Shankar Prasad, Nayak, Satyaprakash

Testo Testo Testo

A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 2 – Application to Current Therapies in Crohn’s Disease di Rogers, Katharine V., Martin, Steven W., Bhattacharya, Indranil, Singh, Ravi Shankar Prasad, Nayak, Satyaprakash

Testo Testo Testo

Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use di Nayak, Satyaprakash, Sander, Oliver, Al‐Huniti, Nidal, de Alwis, Dinesh, Chain, Anne, Chenel, Marylore, Sunkaraneni, Soujanya, Agrawal, Shruti, Gupta, Neeraj, Visser, Sandra A.G.

Testo Testo Testo

Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn’s Disease: The OPERA II Stu... di D’Haens, Geert R, Reinisch, Walter, Lee, Scott D, Tarabar, Dino, Louis, Edouard, Kłopocka, Maria, Klaus, Jochen, Schreiber, Stefan, Il Park, Dong, Hébuterne, Xavier, Nagy, Peter, Cataldi, Fabio, Martin, Steven W, Nayak, Satyaprakash, Banerjee, Anindita, Gorelick, Kenneth J, Sandborn, William J

Testo Testo Testo

Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn’s Disease di Hassan-Zahraee, Mina, Banerjee, Anindita, Cheng, John B, Zhang, Weidong, Ahmad, Alaa, Page, Karen, von Schack, David, Zhang, Baohong, Martin, Steven W, Nayak, Satyaprakash, Reddy, Padma, Xi, Li, Neubert, Hendrik, Fernandez Ocana, Mireia, Gorelick, Ken, Clare, Robert, Vincent, Michael, Cataldi, Fabio, Hung, Kenneth

Testo Testo Testo

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study di Sandborn, William J, Lee, Scott D, Tarabar, Dino, Louis, Edouard, Klopocka, Maria, Klaus, Jochen, Reinisch, Walter, Hébuterne, Xavier, Park, Dong-Il, Schreiber, Stefan, Nayak, Satyaprakash, Ahmad, Alaa, Banerjee, Anindita, Brown, Lisa S, Cataldi, Fabio, Gorelick, Kenneth J, Cheng, John B, Hassan-Zahraee, Mina, Clare, Robert, D’Haens, Geert R

Testo Testo Testo